Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANI Pharmaceuticals

94.10
+0.60000.64%
Pre-market: 94.490.3900+0.41%06:09 EDT
Volume:490.01K
Turnover:46.08M
Market Cap:2.04B
PE:-81.57
High:95.60
Open:93.60
Low:93.23
Close:93.50
52wk High:95.60
52wk Low:52.50
Shares:21.70M
Float Shares:16.97M
Volume Ratio:1.32
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1536
EPS(LYR):-1.0429
ROE:-2.17%
ROA:1.09%
PB:4.68
PE(LYR):-90.23

Loading ...

ANI Pharmaceuticals price target raised to $77 from $65 at Truist

TIPRANKS
·
Aug 11

ANI Pharmaceuticals Inc : Raymond James Raises Target Price to $99 From $86

THOMSON REUTERS
·
Aug 11

Truist Securities Adjusts ANI Pharmaceuticals Price Target to $77 From $65, Maintains Hold Rating

MT Newswires Live
·
Aug 11

Truist Financial Remains a Hold on ANI Pharmaceuticals (ANIP)

TIPRANKS
·
Aug 11

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Simply Wall St.
·
Aug 10

ANI Pharmaceuticals Up Nearly 18%, on Track for Highest Close Since August 2019 -- Data Talk

Dow Jones
·
Aug 09

ANI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 09

ANI Pharmaceuticals price target raised to $93 from $84 at H.C. Wainwright

TIPRANKS
·
Aug 08

Stock Track | ANI Pharmaceuticals Soars 17% on Record Q2 Results and Raised 2025 Guidance

Stock Track
·
Aug 08

ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Aug 08

Sector Update: Health Care Stocks Edge Higher Premarket Friday

MT Newswires Live
·
Aug 08

Cg Oncology (CGON) Q2 Loss Widens 93%

Motley Fool
·
Aug 08

ANI Pharmaceuticals Shares Climb on Outlook Raise as Sales Surge

Dow Jones
·
Aug 08

ANI Pharmaceuticals Q2 Adjusted EPS USD 1.8 Vs. IBES Estimate USD 1.42

Reuters
·
Aug 08

Stock Track | ANI Pharmaceuticals Soars 6.49% Pre-market on Strong Q2 Results and Raised 2025 Guidance

Stock Track
·
Aug 08

Stock Track | ANI Pharmaceuticals Soars 6.49% Pre-market on Strong Q2 Results and Raised 2025 Guidance

Stock Track
·
Aug 08

ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42

TIPRANKS
·
Aug 08

ANI Pharmaceuticals raises FY25 adj. EPS view to $6.98-$7.35 from $6.27-$6.62

TIPRANKS
·
Aug 08

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects Full-Year 2025 Adjusted EPS Range $6.98 - $7.35, vs. FactSet Est of $6.53

MT Newswires Live
·
Aug 08

ANI Pharmaceuticals Q2 2025 Adj. EPS $1.80 Beats $1.39 Estimate, Sales $211.371M Beat $187.797M Estimate

Benzinga
·
Aug 08